Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional payments for other indications; includes contingent R&D investment, tiered sales ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
In preparation for health authority interactions in pursuit of marketing approvals in Europe PRINCETON, N.J., Sept. 30, 2025 /PRNewswire/ -- Soligenix, ...
Pharmaceutical Technology on MSN
NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing
China’s National Medical Products Administration (NMPA) has granted approval for four-weekly intravenous (IV) maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback